Home / Tolterodine / Belgium
BE ATC G04BD07 · updated 2 Nov 2026
Tolterodine shortage in Belgium
Is there a Tolterodine shortage in Belgium?
Yes. As of 2 Nov 2026, 3 Tolterodine products are reported short in Belgium, the first since 6 Aug 2024. The company estimate for the return is 7 Dec 2026 (latest 15 Mar 2027). Main reason: manufacturing problem.
Also short in Canada, Germany, Spain, Ireland, Austria, Norway, Sweden. All countries.
Affected products in Belgium
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| BE | Tolterodine Retard Teva 4 mg hard caps. prol.-rel. 28 | Teva | 6 Aug 2024 | 7 Dec 2026 | Increased demand |
| BE | Tolterodine Retard Teva 4 mg hard caps. prol.-rel. 84 | Teva | 5 Feb 2025 | 15 Mar 2027 | Manufacturing problem Delay in production |
| BE | Urolina 4 mg hard caps. prol.-rel. 84 | Ceres Pharma | 8 Jun 2026 | 10 Feb 2027 | Manufacturing problem Delay in production |
Source
FAMHP (Federal Agency for Medicines and Health Products), PharmaStatus / SAMv2. Official list. All authorised packs with a declared temporary unavailability.